PROTACs Move From Lab Concept to Clinical Reality in Targeted Protein Degradation
A new comprehensive review in Discover Chemistry details how PROTACs have evolved from a mechanistic concept into clinically advanced degraders ...
A new comprehensive review in Discover Chemistry details how PROTACs have evolved from a mechanistic concept into clinically advanced degraders ...
A comprehensive new guideline synthesizes the full landscape of anti-cancer drug clinical research, from preclinical requirements and trial phases to ...
Messenger RNA therapeutics, the technology that vaulted to global prominence through COVID-19 vaccines, is undergoing a decisive transformation in oncology, ...
Dana-Farber Cancer Institute researchers are set to unveil over 50 groundbreaking studies at the upcoming American Association for Cancer Research ...
In the ever-evolving landscape of pharmacology and toxicology, the need for precise and innovative methodologies to quantify drugs and investigate ...
The complex landscape of oncology drug development has long been a subject of intensive research and debate, particularly regarding how ...
In an exciting development in the realm of cancer therapeutics, researchers have unveiled a novel antibody-drug conjugate (ADC) known as ...
In a landmark development in the field of oncology and targeted cancer therapies, researchers at The University of Texas MD ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine